Business Description
HeartBeam Inc
NAICS : 923120
SIC : 5045
ISIN : US42238H1086
Total Employee Number:
17Description
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.77 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 26.8 | |||||
3-Year EPS without NRI Growth Rate | 26.9 | |||||
3-Year FCF Growth Rate | 29.2 | |||||
3-Year Book Growth Rate | -39.7 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 27.36 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 39.29 | |||||
9-Day RSI | 36.82 | |||||
14-Day RSI | 37.36 | |||||
3-1 Month Momentum % | -35.35 | |||||
6-1 Month Momentum % | -62.59 | |||||
12-1 Month Momentum % | -61.21 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.66 | |||||
Quick Ratio | 3.61 | |||||
Cash Ratio | 3.55 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -71.1 | |||||
Shareholder Yield % | -71.22 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -634.13 | |||||
ROA % | -346.75 | |||||
ROIC % | -1801.87 | |||||
ROC (Joel Greenblatt) % | -1895.95 | |||||
ROCE % | -637.63 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 2.87 | |||||
Price-to-Tangible-Book | 2.87 | |||||
EV-to-EBIT | -0.76 | |||||
EV-to-Forward-EBIT | -1.37 | |||||
EV-to-EBITDA | -0.76 | |||||
EV-to-Forward-Revenue | 3.36 | |||||
EV-to-FCF | -1.15 | |||||
| Price-to-Net-Current-Asset-Value | 3.58 | |||||
| Price-to-Net-Cash | 3.91 | |||||
Earnings Yield (Greenblatt) % | -131.58 | |||||
FCF Yield % | -55.77 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BEAT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HeartBeam Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.51 | ||
| Beta | 0.9113 | ||
| 3-Year Sharpe Ratio | 0.13 | ||
| 3-Year Sortino Ratio | 0.31 | ||
| Volatility % | 240.09 | ||
| 14-Day RSI | 37.36 | ||
| 14-Day ATR ($) | 0.033524 | ||
| 20-Day SMA ($) | 0.48802 | ||
| 12-1 Month Momentum % | -61.21 | ||
| 52-Week Range ($) | 0.4011 - 4 | ||
| Shares Outstanding (Mil) | 56.35 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
HeartBeam Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
HeartBeam Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-13 16:30 | In 66 days | ||
| Third quarter earnings results for 2026 | 2026-11-13 | In 65 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-13 16:30 | 0.57 (-3.75%) | ||
| Second quarter earnings results for 2026 | 2026-08-13 | 0.57 (-3.75%) | ||
| General meeting for 2026 | 2026-07-31 13:00 | 0.52 (+3.23%) | ||
| First quarter earnings conference call for 2026 | 2026-05-13 16:30 | 0.91 (-1.01%) | ||
| First quarter earnings results for 2026 | 2026-05-13 | 0.91 (-1.01%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-12 16:30 | 1.36 (+0.00%) | ||
| Annual report for 2025 | 2026-03-12 | 1.36 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-12 | 1.36 (+0.00%) |
Show
Entries
HeartBeam Inc Frequently Asked Questions
What is HeartBeam Inc(BEAT)'s stock price today?
The current price of BEAT is $0.43. The 52 week high of BEAT is $4.00 and 52 week low is $0.40.
When is next earnings date of HeartBeam Inc(BEAT)?
The next earnings date of HeartBeam Inc(BEAT) is 2026-11-13 Est..
Does HeartBeam Inc(BEAT) pay dividends? If so, how much?
HeartBeam Inc(BEAT) does not pay dividend.
Press Release
Articles on HeartBeam Inc
HeartBeam Inc (BEAT) (Q2 2026) Earnings Call Highlights: FDA Submission Advances and Commercial Launch Gains Momentum
Aug 14, 2026
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers